Impact of the healthcare reorganization of the Local Health Authority services in Rieti (Italy) during the SARS-CoV-2 pandemic
Keywords:
COVID-19, organizational actions, diagnosis, hospitalisation, managementAbstract
Background. The need to contain the spread of the SARS-CoV-2 pandemic has forced national and local organizations to define and implement targeted emergency response and management measures. As the knowledge about the infection grew, a wider range of organizational measures were deployed.
Methods. This study involves the SARS-CoV-2 infected people managed by the Local Health Authority of Rieti (Italy). Diagnostic test waiting times and hospital admission rates in the Province of Rieti are investigated as the pandemic evolved. Trends were analyzed in relation to the tempora spreading of SARS-CoV-2, to the organizational actions taken by the Local Health Authority of Rieti, and to the deployment of actions across the territory. A municipalities classification of the province of Rieti was conducted after a cluster analysis based on the diagnostic test waiting times and the hospital admission rates.
Results. Our findings show a declining trend, thus indicating a possible positive effect of the measures taken to contain the pandemic.
The cluster analysis of the municipalities of the Province of Rieti makes evident an inhomogeneous geographical distribution of examined parameters (diagnostic test waiting times and the hospital admission rates), demonstrating the capability of Local Health Authority of Rieti to reach even the most disadvantaged areas and implying that the differences are due to the demographical variabilities.
Conclusion. Despite some limitations, this study outlines the importance of management measures in response of the pandemic. These measures should adapt to social, cultural and geographical nature of the territory involved. The findings of the present study will contribute to the update of further pandemic preparedness plans of the Local Health Authorities.
References
1. World Health Organization (WHO). WHO
Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Available on: https://www.who.int/director-general/ speeches/detail/who-director-general-s-openingremarks-at-the-media-briefing-on-covid-19--11-march-2020 [Last accessed: 2023 January 11].
2. Decreto del Presidente del Consiglio dei Ministri 8 marzo 2020. Gazzetta Ufficiale della Repubblica Italiana – Serie Generale n. 59, 8 marzo 2020.
3. Ordinanza del Presidente della Regione Lazio
n. Z00002 del 26 aprile 2020.
4. Kucharski AJ, Klepac P, Conlan AJK, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020 Oct; 20(10): 1151-60. doi: 10.1016/ S1473-3099(20)30457-6. Epub 2020 Jun 16.
5. Park YJ, Choe YJ, Park O, et al. Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerg Infect Dis. 2020 Oct; 26(10):2465-8. doi: 10.3201/eid2610.201315. Epub 2020 Jul 16.
6. Test diagnostici, contact tracing, isolamento e autosorveglianza. Available on: www.salute.gov. it [Last accessed: 2022 October 12].
7. Park Y, Huh IS, Lee J, et al. Application of Testing-Tracing-Treatment Strategy in Response to the COVID-19 Outbreak in Seoul, Korea. J Korean Med Sci. 2020 Nov 23; 35(45): e396.
https://doi.org/10.3346/jkms.2020.35.e396.
8. Kwon KT, Ko JH, Shin H, Sung M, Kim JY. Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak J Korean Med Sci. 2020 Mar 23; 35(11): e123. doi: 10.3346/ jkms.2020.35.e123.
9. Constantine ST, Callaway D, Driscoll JN, Murphy S. Implementation of Drive-Through Testing for COVID-19 With Community Paramedics. Disaster Med Public Health Prep. 2021 Feb 16: 1-7. doi: 10.1017/dmp.2021.46. Epub ahead of print.
10. Decreto Ministro della Salute 2 gennaio 2021. Adozione del Piano strategico nazionale dei vaccini per la prevenzione delle infezioni da SARS-CoV-2.
11. Salian VS, Wright JA, Vedell PT, et al. COVID19 Transmission, Current Treatment, and Future Therapeutic Strategies. Mol Pharm.
2021 Mar 1; 18(3): 754-71. doi: 10.1021/acs.
molpharmaceut.0c00608. Epub 2021 Jan 19.
12. Burns J, Movsisyan A, Stratil JM, et al. Travel-related control measures to contain the COVID-19 pandemic: a rapid review. Cochrane Database Syst Rev. 2020 Oct 5; 10: CD013717. doi: 10.1002/14651858.CD013717. Update in: Cochrane Database Syst Rev. 2021 Mar 25; 3: CD013717.
13. Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020 Mar 18; 10(1): 33. doi: 10.1186/s13613-020-00650-2.
14. Riffenburgh RH. Statistics in medicine. 3rd ed.
©Elsevier; 2012. https://doi.org/10.1016/C20100-64822-X.
15. Hartigan JA, Wong MA. Algorithm AS 136: A K-means clustering algorithm. J R Stat Soc Ser C Appl Stat. 1979; 28(1): 100-8. doi: 10.2307/2346830.
16. Gruppo di lavoro ISS Bioetica COVID-19. Supporto digitale al tracciamento dei contatti (contact tracing) in pandemia: considerazioni di
etica e di governance. Versione del 17 settembre 2020. Roma: Istituto Superiore di Sanità; 2020 (Rapporto ISS COVID-19 n. 59/2020).
17. Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021 May 15; 397(10287): 1819-29. doi: 10.1016/S01406736(21)00947-8. Epub 2021 May 5.
18. Lopez Bernal J, Andrews N, Gower C, et al Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccine on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative casecontrol study. BMJ. 2021 May 13; 373: n1088. doi: 10.1136/bmj.n1088.
19. Corti D, Purcell LA, Snell G, Veesler D. Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021 Jun 10; 184(12): 3086-3108. doi: 10.1016/j.cell.2021.05.005. Epub 2021 May 26.
20. Mamo C, Dalmasso M, Pasqualini O, et al. Durata di isolamento dei casi COVID-19 nella prima ondata epidemica in unASL della Città Metropolitana di Torino. Boll Epidemiol Naz
2021; 2(3): 26-35. doi: https://doi.org/10.53225/
BEN_021.
21. Istituto Nazionale di Satatistica (ISTAT). Indicatori demografici, anno 2020.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.